Signaling Pathways - DCLK2 - P-glycoprotein (P-gp) - GLI - Neuraminidases (NA)
清除全部
-
B1803 Oseltamivir phosphate1 Citation中文名: 磷酸奥司他韦Target: Neuraminidases (NA)Summary: 有效的选择性神经氨酸酶抑制剂 -
A8549 LY335979 (Zosuquidar 3HCL)1 Citation中文名: 唑喹达三盐酸盐Target: P-glycoprotein (P-gp)Summary: Pgb（P糖蛋白）抑制剂 -
A1615 GANT611 CitationTarget: GLISummary: GLI拮抗剂 -
A3956 ZosuquidarTarget: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)Summary: MDR调节剂 -
A3944 X-NeuNAcTarget: Neuraminidases (NA)Summary: 神经氨酸酶活性显色试验的底物 -
A3859 Tariquidar methanesulfonate, hydrate中文名: 他立喹达二甲磺酸盐六水合物Target: P-glycoprotein (P-gp)Summary: P-糖蛋白抑制剂 -
A3689 Oseltamivir acid1 Citation中文名: 奥斯他伟酸，奥司他韦羧酸，奥司他韦酸，奥塞米韦酸Target: Neuraminidases (NA)Summary: 流感神经氨酸酶抑制剂 -
A3558 LRRK2-IN-11 CitationTarget: LRRK2|DCLK2Summary: LRRK2抑制剂 -
A3384 Elacridar中文名: 依克立达Target: P-glycoprotein (P-gp)Summary: BCRP抑制剂 -
A8208 Tariquidar2 Citation中文名: 他立喹达Target: P-glycoprotein (P-gp)Summary: P-糖蛋白抑制剂